Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 2, 2026.

β ‐Amyloid Degradation and Alzheimer′s Disease

Deng-Shun Wang, Dennis W. Dickson, James S. Malter

BioMed Research International · 2006 · CC BY

doi:10.1155/jbb/2006/58406

Abstract

Extensive β ‐amyloid (A β ) deposits in brain parenchyma in the form of senile plaques and in blood vessels in the form of amyloid angiopathy are pathological hallmarks of Alzheimer′s disease (AD). The mechanisms underlying A β deposition remain unclear. Major efforts have focused on A β production, but there is little to suggest that increased production of A β plays a role in A β deposition, except for rare familial forms of AD. Thus, other mechanisms must be involved in the accumulation of A β in AD. Recent data shows that impaired clearance may play an important role in A β accumulation in the pathogenesis of AD. This review focuses on our current knowledge of A β ‐degrading enzymes, including neprilysin (NEP), endothelin‐converting enzyme (ECE), insulin‐degrading enzyme (IDE), angiotensin‐converting enzyme (ACE), and the plasmin/uPA/tPA system as they relate to amyloid deposition in AD.

Cited by papers we hold 8

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.